Biocept Announces Agreement with Aegea Biotechnologies to Develop New, Highly Sensitive PCR-based COVID-19 Assay Utilizing Patented Switch-Blocker PCR Technology
Stock Information for Biocept Inc.
Loading
Please wait while we load your information from QuoteMedia.